Delivery Order SPE2DB22D1002-SPE2DB25FLGK8
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,775.04 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used to treat attention-deficit/hyperactivity disorder and binge...
- The Defense Logistics Agency awarded a delivery order valued at $2,189.62 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Vyvanse 30 mg capsules (100 count). This non-set-aside, firm fixed price delivery order is scheduled for ultimate completion on August 6, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Vyvanse is a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and binge eating disorder,...
- The Defense Logistics Agency awarded a delivery order valued at $6,321.44 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication used in the treatment of attention deficit hyperactivity...
- The Defense Logistics Agency awarded a delivery order valued at $4,991.73 to AmerisourceBergen Drug Corp for the supply of Vyvanse 50 mg capsules (100 count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania facility. Vyvanse is a prescription stimulant medication commonly used to treat attention deficit...
- The Defense Logistics Agency awarded a $3,007.07 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 50 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. The contract was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,735.43 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is executed as a child order under AmerisourceBergen's larger prime contract vehicle. The pharmaceutical product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,337.70 on July 21, 2025, for the supply of Vyvanse 20 mg capsules (100-count units). This firm fixed-price delivery order, which is expected to be completed by July 22, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vyvanse is a prescription medication commonly used in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,519.62 for 100 capsules of Vyvanse 30 mg, a prescription medication commonly used to treat attention deficit hyperactivity disorder. This competitively awarded, firm fixed-price delivery order has a completion date of August 1, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was open to all...
- The Defense Logistics Agency awarded a delivery order valued at $7,637.24 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 10 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, was issued without a set-aside designation and represents a competitively awarded transaction. The pharmaceutical supplies will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,241.46 to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...